MESO
Price
$14.38
Change
+$0.86 (+6.36%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
1.78B
81 days until earnings call
SLGL
Price
$27.96
Change
-$0.04 (-0.14%)
Updated
Sep 5, 04:57 PM (EDT)
Capitalization
77.89M
61 days until earnings call
Interact to see
Advertisement

MESO vs SLGL

Header iconMESO vs SLGL Comparison
Open Charts MESO vs SLGLBanner chart's image
Mesoblast
Price$14.38
Change+$0.86 (+6.36%)
Volume$2.06K
Capitalization1.78B
Sol-Gel Technologies
Price$27.96
Change-$0.04 (-0.14%)
Volume$1.25K
Capitalization77.89M
MESO vs SLGL Comparison Chart in %
Loading...
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MESO vs. SLGL commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MESO is a Hold and SLGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (MESO: $14.39 vs. SLGL: $27.96)
Brand notoriety: MESO and SLGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MESO: 185% vs. SLGL: 119%
Market capitalization -- MESO: $1.78B vs. SLGL: $77.89M
MESO [@Biotechnology] is valued at $1.78B. SLGL’s [@Biotechnology] market capitalization is $77.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MESO’s FA Score shows that 0 FA rating(s) are green whileSLGL’s FA Score has 0 green FA rating(s).

  • MESO’s FA Score: 0 green, 5 red.
  • SLGL’s FA Score: 0 green, 5 red.
According to our system of comparison, SLGL is a better buy in the long-term than MESO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MESO’s TA Score shows that 7 TA indicator(s) are bullish while SLGL’s TA Score has 2 bullish TA indicator(s).

  • MESO’s TA Score: 7 bullish, 3 bearish.
  • SLGL’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, MESO is a better buy in the short-term than SLGL.

Price Growth

MESO (@Biotechnology) experienced а +4.05% price change this week, while SLGL (@Biotechnology) price change was +22.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

MESO is expected to report earnings on Nov 26, 2025.

SLGL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MESO($1.78B) has a higher market cap than SLGL($77.9M). SLGL YTD gains are higher at: 201.043 vs. MESO (-31.717). SLGL has higher annual earnings (EBITDA): -4.59M vs. MESO (-77.78M). MESO has more cash in the bank: 37.7M vs. SLGL (24.3M). SLGL has less debt than MESO: SLGL (1.18M) vs MESO (126M). SLGL has higher revenues than MESO: SLGL (23.9M) vs MESO (5.67M).
MESOSLGLMESO / SLGL
Capitalization1.78B77.9M2,281%
EBITDA-77.78M-4.59M1,694%
Gain YTD-31.717201.043-16%
P/E RatioN/AN/A-
Revenue5.67M23.9M24%
Total Cash37.7M24.3M155%
Total Debt126M1.18M10,660%
FUNDAMENTALS RATINGS
MESO vs SLGL: Fundamental Ratings
MESO
SLGL
OUTLOOK RATING
1..100
6772
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
5234
P/E GROWTH RATING
1..100
9798
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLGL's Valuation (53) in the Pharmaceuticals Major industry is somewhat better than the same rating for MESO (87) in the Biotechnology industry. This means that SLGL’s stock grew somewhat faster than MESO’s over the last 12 months.

SLGL's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as MESO (100) in the Biotechnology industry. This means that SLGL’s stock grew similarly to MESO’s over the last 12 months.

SLGL's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as MESO (96) in the Biotechnology industry. This means that SLGL’s stock grew similarly to MESO’s over the last 12 months.

SLGL's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as MESO (52) in the Biotechnology industry. This means that SLGL’s stock grew similarly to MESO’s over the last 12 months.

MESO's P/E Growth Rating (97) in the Biotechnology industry is in the same range as SLGL (98) in the Pharmaceuticals Major industry. This means that MESO’s stock grew similarly to SLGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MESOSLGL
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OBMCX50.790.81
+1.62%
Oberweis Micro-Cap
LMPOX35.510.50
+1.43%
ClearBridge Small Cap Growth R
RPFCX66.190.51
+0.78%
Davis Balanced Fund A
ACEIX11.130.06
+0.54%
Invesco Equity and Income A
SIIAX16.420.04
+0.24%
AlphaCentric Real Income A

MESO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been loosely correlated with QTTB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MESO jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
+4.97%
QTTB - MESO
51%
Loosely correlated
-2.92%
SLGL - MESO
37%
Loosely correlated
+19.66%
AVTX - MESO
32%
Poorly correlated
-3.74%
ZURA - MESO
30%
Poorly correlated
+1.97%
PRTA - MESO
28%
Poorly correlated
-2.15%
More

SLGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLGL has been loosely correlated with TRAW. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SLGL jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLGL
1D Price
Change %
SLGL100%
+19.66%
TRAW - SLGL
47%
Loosely correlated
+3.42%
NEUP - SLGL
40%
Loosely correlated
-8.31%
RAPT - SLGL
39%
Loosely correlated
+12.65%
AZTR - SLGL
33%
Poorly correlated
-9.79%
GTBP - SLGL
33%
Poorly correlated
-1.16%
More